Project Grant R43AG082596
Award Date
9/25/24
Completion Date
8/31/25
Dollars Obligated
$811K
Federal Agency
National Institute on Aging
Awardee
B.a. Maze, Inc. (FJ4SVZZPD654)
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Kentucky, USA
Similar Awards
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) totaling $499,758 provides funding to Aster Labs, Inc. to develop an automated system for detecting and reporting lapses in the performance of activities of daily living (ADLs) for individuals with Alzheimer's disease and related dementias. The ActivVerify system will leverage sensor data from a discreet shoe insole hardware suite to automatically detect and verify ADL compliance, providing caregivers...
This $1,230,000 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) supports the development and delivery of closed-loop digital interventions through a remote clinical trials platform at the University of California, San Francisco (UCSF). The overarching goal is to leverage technology to facilitate memory and cognitive function in older adults, particularly those at risk of Alzheimer's disease and related dementias. The award will fund a Behavioral...
The federal Project Grant award of $2,399,431 from the National Institute on Aging's Aging Research Federal Grant Program (CFDA 93.866) will fund the development of a digital cognitive health resource based on the Boston University Alzheimer's Disease Research Center (BU ADRC) cohort. The project aims to collect longitudinal digital cognitive phenotypes via digital recorder, digital pen, and smartphone applications, and then assess the relationship of these digital cognitive metrics with...
The National Institute on Aging (NIA), under the Aging Research Federal Grant Program (CFDA 93.866), awarded a $1,010,368 Project Grant to Koronis Biomedical Technologies Corporation (KBT) to develop and validate a novel cognitive intervention system to support informal caregivers and families of individuals living with mild cognitive impairment (MCI), Alzheimer's disease (AD), or other related dementias (ADRD). The proposed research aims to create an in-home cognitive training platform that...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to Amissa Inc. is focused on developing technology solutions to monitor cognitive function and detect preclinical Alzheimer's disease in older adults. The $1,011,032 award supports research activities spanning two key aims: Assessing the relationship between health data collected from smartwatches (e.g. Apple Watch) and cognitive function in older adults with and without preclinical Alzheimer's, and...
The Department of Health and Human Services' National Institutes of Health's National Institute on Aging awarded $865,905 under the Aging Research program (CFDA 93.866) to Careband, Inc. to develop the Appraise to Assist system. This project grant will support Careband and its partner Eperture LLC to engineer a system integrating Careband's wearable device and Eperture's tablet platform. The system aims to passively and unobtrusively monitor, empirically measure, and facilitate engagement...
The National Institute on Aging (NIA) awarded a $835,056 Project Grant (CFDA 93.866 - Aging Research) to Trustees of Tufts College (Tufts University) to develop a multi-modal system of wearable biosensors and machine learning algorithms for continuous monitoring of mobility and cognitive function in older adults. The goal is to enable early detection and prediction of Alzheimer's disease and related dementias (AD/ADRD) by capturing subtle changes in biophysical domains like gait, posture, and...
This federal Project Grant award for $2,169,736 was provided by the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866). The objective is to develop an "Intelligent Social Risk Management" (ISMART) platform that can be integrated into electronic health record (EHR) systems to improve care and quality of life for people living with dementia (PLWD), particularly those from racial/ethnic minority or socioeconomically disadvantaged groups. The key products to...
This $1,177,500 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports the development of infrastructure and clinical trials for technology-enabled behavioral and lifestyle change interventions targeting older adults living alone with cognitive decline. The goal is to delay Alzheimer's disease and improve quality of life in this population, with a focus on addressing social support, stress, and emotional wellbeing through mechanisms of behavior change....
This $449,999 federal Project Grant award from the Agency for Healthcare Research and Quality (CFDA 93.226 - Research on Healthcare Costs, Quality and Outcomes) aims to improve long-term care (LTC) quality and safety, particularly for persons living with dementia, by implementing evidence-based decision support technologies (DS Tech). The key objectives are to: 1) characterize LTC contexts to identify implementation requirements for effective DS Tech, 2) implement and evaluate two DS Tech...